Your browser doesn't support javascript.
loading
Proposition of a structured list of information items to be transmitted to primary caregivers after in-hospital medication optimization: a qualitative study.
Visade, Fabien; Lefebvre, Antoine; Floret, Emmanuel; Decaudin, Bertrand; Puisieux, François; Delecluse, Céline; Beuscart, Jean-Baptiste.
Affiliation
  • Visade F; Geriatrics Department, Lille Catholic Hospitals, University of Lille, Lomme, France.
  • Lefebvre A; Univ. Lille, EA2694 - Evaluation des Technologies de Santé et des Pratiques Médicales, F-59000 Lille, France.
  • Floret E; Department of Pharmacy, Lille Catholic Hospitals, University of Lille, Lomme, France.
  • Decaudin B; Department of Pharmacy, Lille Catholic Hospitals, University of Lille, Lomme, France.
  • Puisieux F; Univ. Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France.
  • Delecluse C; CHU Lille, Department of pharmacology, F-59000 Lille, France.
  • Beuscart JB; CHU Lille, Department of pharmacology, F-59000 Lille, France.
Acta Clin Belg ; 76(3): 184-189, 2021 Jun.
Article in En | MEDLINE | ID: mdl-31787034
ABSTRACT
Background and

objective:

Defective transmission of drug information during the transition from hospital to home care are causes of adverse drug reactions in older patients. We aimed to reach a consensus concerning information about changes in treatment to be transmitted to primary caregivers when an older patient is discharged from hospital.

Methods:

A qualitative focus group study was conducted with general practitioners, geriatricians, community pharmacists, and hospital pharmacists providing care for older patients. Four steps were used to reach a focus group consensus 1) presentation of the purpose of the focus group; 2) generation and enumeration of ideas; 3) sharing opinions about these ideas; 4) voting to create a list of ranked items. The process involved three focus groups.

Results:

A consensus was reached on ten items indication for continued, discontinued, newly introduced or changed treatments and their duration; reasons for discontinuing drugs or introducing new drugs; information about re-evaluating treatments; reasons for hospital stay, significant elements and diagnosis at discharge; administrative information concerning the patient; the name of the primary care physician, and the discharging hospital unit and the physician(s) in charge; known allergies, information about liver and kidney failure; main adverse effects to monitor; date of latest blood tests; hospital admission/discharge dates.

Conclusion:

The consensus on the list of information items concerning changes in the treatment should be used by hospital physicians and pharmacists to ensure safe patient discharge.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Caregivers / General Practitioners Type of study: Qualitative_research Limits: Aged / Humans Language: En Journal: Acta Clin Belg Year: 2021 Document type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Caregivers / General Practitioners Type of study: Qualitative_research Limits: Aged / Humans Language: En Journal: Acta Clin Belg Year: 2021 Document type: Article Affiliation country: France